Pharmaceutical Technology1h
Risk adjusted net present value: What is the current valuation of Eli Lilly and Co’s Olomorasib?
Olomorasib is a small molecule commercialized by Eli Lilly and Co, with a leading Phase III program in Non-Small Cell Lung Cancer.
Pharmaceutical Technology1h
Risk adjusted net present value: What is the current valuation of Pfizer’s Ponsegromab?
Ponsegromab is a monoclonal antibody commercialized by Pfizer, with a leading Phase II program in Cancer Anorexia-Cachexia Syndrome.
Pharmaceutical Technology4h
Risk adjusted net present value: What is the current valuation of GSK’s Linerixibat?
Linerixibat is a small molecule commercialized by GSK, with a leading Phase III program in Pruritus. According to Globaldata, it is involved in 15 clinical trials, of which 12 were completed, and 3 ...
Pharmaceutical Technology4h
Risk adjusted net present value: What is the current valuation of Enanta Pharmaceuticals’s Zelicapavir?
Zelicapavir is a small molecule commercialized by Enanta Pharmaceuticals, with a leading Phase II program in Respiratory Syncytial Virus (RSV) Infections.
Pharmaceutical Technology4h
Risk adjusted net present value: What is the current valuation of Eli Lilly and Co’s Lepodisiran sodium?
Lepodisiran sodium is an antisense rnai oligonucleotide commercialized by Eli Lilly and Co, with a leading Phase III program in Atherosclerosis.
Pharmaceutical Technology4h
Risk adjusted net present value: What is the current valuation of Oncolytics Biotech’s Reolysin?
Reolysin is an oncolytic virus commercialized by Oncolytics Biotech, with a leading Phase II program in Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast Cancer).
Pharmaceutical Technology8h
Flu vaccine strategy on the line as new US leaders anticipated to take charge
RFK Jr’s appointment as HHS head is likely to shake up flu vaccine regulation, say experts. Credit: The Washington Post via Getty Images As countries in the Northern hemisphere deal with the flu ...
Pharmaceutical Technology8h
Risk adjusted net present value: What is the current valuation of Milestone Pharmaceuticals’s Etripamil?
Etripamil is a small molecule commercialized by Milestone Pharmaceuticals, with a leading Pre-Registration program in Supraventricular Tachycardia. According to Globaldata, it is involved in 13 ...
Pharmaceutical Technology8h
Risk adjusted net present value: What is the current valuation of United Therapeutics’s Ralinepag?
The revenue for Ralinepag is expected to reach an annual total of $131 mn by 2035 in the US based off GlobalData’s Expiry Model. The drug’s revenue forecasts along with estimated costs are used to ...
Pharmaceutical Technology14h
Nobel laureates ‘strongly urge’ Senate to oppose confirmation of RFK Jr
In the letter, 77 Nobel Prize winners argue that appointing RFK as Secretary of HHS would put the US public’s health in jeopardy.
Pharmaceutical Technology16h
How Pfizer management outplayed activist investor Starboard
The push to replace Albert Bourla as Pfizer’s CEO drew attention from the pharma industry but was soon derailed by several events.